Works matching Rifampin (drug interactions)

Results: 67

Predicting Interactions between Rifampin and Antihypertensive Drugs Using the Biopharmaceutics Drug Disposition Classification System.

Published in:

Pharmacotherapy, 2020, v. 40, n. 4, p. 274, doi. 10.1002/phar.2380

By:

Liu, Wei;
Yan, Tingting;
Chen, Ken;
Yang, Li;
Benet, Leslie Z.;
Zhai, Suodi

Publication type:

Article

Rifampin - Risperidone and Divalproex Drug-drug Interaction: A Case Report.

Published in:

2023

By:

Seo-Young Park;
Young-Min Park

Publication type:

Case Study

Drug interaction between mycophenolate mofetil and rifampin: Possible induction of uridine diphosphate-glucuronosyltransferase

Published in:

Clinical Pharmacology & Therapeutics, 2005, v. 78, n. 1, p. 81, doi. 10.1016/j.clpt.2005.03.004

By:

Kuypers, Dirk R.J.;
Verleden, Geert;
Naesens, Maarten;
Vanrenterghem, Yves

Publication type:

Article

Linezolid and rifampin: Drug interaction contrary to expectations?

Published in:

2005

By:

Hannes Egle;
Rainer Trittler;
Sebastian W. Lemmen

Publication type:

Letter

Drug interaction occurs in patient on clozapine, rifampin.

Published in:: Brown University Psychopharmacology Update, 1998, v. 9, n. 5, p. 8
Publication type:: Article

Unsuspected and Paradoxical Potential for Drug Interaction by Rifampin: Things to Ponder with Antiretroviral Therapy.

Published in:

2009

By:

Srinivas, Nuggehally R.

Publication type:

Letter

Rifampin and Warfarin: A Drug Interaction.

Published in:

Annals of Internal Medicine, 1975, v. 82, n. 2, p. 224, doi. 10.7326/0003-4819-82-2-224

By:

Romankiewicz, John A.;
Ehrman, Mark

Publication type:

Article

A literature review of liver function test elevations in rifampin drug–drug interaction studies.

Published in:

CTS: Clinical & Translational Science, 2022, v. 15, n. 7, p. 1561, doi. 10.1111/cts.13281

By:

Ibrahim, Sherry M.;
Pithavala, Yazdi K.;
Vourvahis, Manoli;
Chen, Joseph

Publication type:

Article

A Case to Support the Continued Use of Rifampin in Clinical Drug–Drug Interaction Studies.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 1, p. 34, doi. 10.1002/cpt.3256

By:

Bercu, Joel P.;
Ponting, David J.;
Ripp, Sharon L.;
Dobo, Krista L.;
Totah, Rheem A.;
Bolleddula, Jayaprakasam

Publication type:

Article

A case series of the rifampin-warfarin drug interaction: focus on practical warfarin management.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 3, p. 341, doi. 10.1007/s00228-020-03057-x

By:

Yang, Charlotte S.;
Boswell, Rosaleen;
Bungard, Tammy J.

Publication type:

Article

High Prescription Rate of Medications With Rifampin Drug–drug Interactions in Patients With Diabetic Foot Osteomyelitis: Should Rifabutin Be Included in Clinical Trials for Adjunctive Therapy?

Published in:

Open Forum Infectious Diseases, 2024, v. 11, n. 11, p. 1, doi. 10.1093/ofid/ofae582

By:

Mallarino-Haeger, Christina;
Watson, Allison;
Mahgoub, Umnia;
Francis, Lily;
Heydari, Maryam;
Choudhary, Muaaz;
Garcia-Toca, Manuel;
Patel, Manish;
Kempker, Russell R;
Fayfman, Maya;
Schechter, Marcos C

Publication type:

Article

Pharmacokinetic Evaluation of CYP3A4-Mediated Drug-Drug Interactions of Isavuconazole With Rifampin, Ketoconazole, Midazolam, and Ethinyl Estradiol/Norethindrone in Healthy Adults.

Published in:

Clinical Pharmacology in Drug Development, 2017, v. 6, n. 1, p. 44, doi. 10.1002/cpdd.285

By:

Townsend, Robert;
Dietz, Albert;
Hale, Christine;
Akhtar, Shahzad;
Kowalski, Donna;
Lademacher, Christopher;
Lasseter, Kenneth;
Pearlman, Helene;
Rammelsberg, Diane;
Schmitt‐Hoffmann, Anne;
Yamazaki, Takao;
Desai, Amit

Publication type:

Article

Phenytoin-Rifampin Drug Interaction in a Hypoalbuminemic, Renal Failure Patient: A Complex Clinical Case.

Published in:

Pharmacotherapy, 2013, v. 33, n. 6, p. e96, doi. 10.1002/phar.1239

By:

Berkel, Megan A.;
Hurdle, April C.;
Twilla, Jennifer D.

Publication type:

Article

Pharmacokinetic Drug Interactions of Apatinib With Rifampin and Itraconazole.

Published in:

Journal of Clinical Pharmacology, 2018, v. 58, n. 3, p. 347, doi. 10.1002/jcph.1016

By:

Liu, Xiaoyun;
Zhang, Yifan;
Chen, Qian;
Zhan, Yan;
Wang, Quanren;
Hu, Chaoying;
Yu, Chen;
Guo, Zitao;
Chen, Xiaoyan;
Zhong, Dafang

Publication type:

Article

Rifampin-zotepine interaction reduces effectiveness of antipsychotic drugs in a stable schizophrenia patient.

Published in:

Psychiatry & Clinical Neurosciences, 2012, v. 66, n. 6, p. 538, doi. 10.1111/j.1440-1819.2012.02370.x

By:

Pai, Ming‐Shang;
Yang, Szu‐Nian;
Shiah, I‐Shin

Publication type:

Article

Rifampin's Acute Inhibitory and Chronic Inductive Drug Interactions: Experimental and Model-Based Approaches to Drug-Drug Interaction Trial Design.

Published in:

Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 2, p. 234, doi. 10.1038/clpt.2010.271

By:

Reitman, M. L.;
Chu, X.;
Cai, X.;
Yabut, J.;
Venkatasubramanian, R.;
Zajic, S.;
Stone, J. A.;
Ding, Y.;
Witter, R.;
Gibson, C.;
Roupe, K.;
Evers, R.;
Wagner, J. A.;
Stoch, A.

Publication type:

Article

Drug interaction between rifampin and haloperidol concomitantly administered to schzophrenics.

Published in:

Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 2, p. 180, doi. 10.1038/sj.clpt.1996.220

By:

Shin, J.G.;
Kim, Y.H.;
Yoon, Y.R.;
Cha, I.J.;
Jang, I.J.;
Shln, S.G.

Publication type:

Article

The mechanism of the warfarin-rifampin drug interaction in humans.

Published in:

Clinical Pharmacology & Therapeutics, 1987, v. 42, n. 4, p. 388, doi. 10.1038/clpt.1987.168

By:

Heimark, Larry D;
Gibaldi, Milo;
Trager, William F;
O'Reilly, Robert A;
Goulart, Darklis A

Publication type:

Article

Physiologically Based Pharmacokinetic Modelling of Cabozantinib to Simulate Enterohepatic Recirculation, Drug–Drug Interaction with Rifampin and Liver Impairment.

Published in:

Pharmaceutics, 2021, v. 13, n. 6, p. 778, doi. 10.3390/pharmaceutics13060778

By:

Gerner, Bettina;
Scherf-Clavel, Oliver

Publication type:

Article

N<sup>1</sup>‐Methylnicotinamide as Biomarker for MATE‐Mediated Renal Drug–Drug Interactions: Impact of Cimetidine, Rifampin, Verapamil, and Probenecid.

Published in:

Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1070, doi. 10.1002/cpt.2849

By:

Müller, Fabian;
Hohl, Kathrin;
Keller, Sascha;
Schmidt‐Gerets, Sven;
Deutsch, Birgit;
Schuler‐Metz, Annette;
Fromm, Martin F.;
Stopfer, Peter;
Gessner, Arne

Publication type:

Article

Rifampin Drug–Drug–Interaction Studies: Reflections on the Nitrosamine Impurities Issue.

Published in:

Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 4, p. 816, doi. 10.1002/cpt.2652

By:

van Haarst, Aernout;
Smith, Stephen;
Garvin, Clare;
Benrimoh, Natacha;
Paglialunga, Sabina

Publication type:

Article

Sensitivity of ivacaftor to drug‐drug interactions with rifampin, a cytochrome P450 3A4 inducer.

Published in:

Pediatric Pulmonology, 2018, v. 53, n. 5, p. E6, doi. 10.1002/ppul.23971

By:

Guimbellot, Jennifer S.;
Acosta, Edward P.;
Rowe, Steven M.

Publication type:

Article

Rifabutin Use in Staphylococcus Biofilm Infections: A Case Series.

Published in:

Antibiotics (2079-6382), 2020, v. 9, n. 6, p. 326, doi. 10.3390/antibiotics9060326

By:

Doub, James B.;
Heil, Emily L.;
Ntem-Mensah, Afua;
Neeley, Renaldo;
Ching, Patrick R.

Publication type:

Article

395. Safety and Tolerability of Rifampin in Staphylococcal Orthopedic Infections.

Published in:

Open Forum Infectious Diseases, 2019, v. 6, p. S202, doi. 10.1093/ofid/ofz360.468

By:

Miller, Andy O;
Kapadia, Milan;
Carli, Alberto V;
Brause, Barry;
Henry, Michael

Publication type:

Article

Physiologically Based Pharmacokinetic Modeling of the Drug–Drug Interaction Between CYP3A4 Substrate Glasdegib and Moderate CYP3A4 Inducers in Lieu of a Clinical Study.

Published in:

Journal of Clinical Pharmacology, 2024, v. 64, n. 1, p. 80, doi. 10.1002/jcph.2348

By:

Callegari, Ernesto;
Tse, Susanna;
Doran, Angela C.;
Goosen, Theunis C.;
Shaik, Naveed

Publication type:

Article

Comparison of uptake transporter functions in hepatocytes in different species to determine the optimal model for evaluating drug transporter activities in humans.

Published in:

Xenobiotica, 2019, v. 49, n. 7, p. 852, doi. 10.1080/00498254.2018.1512017

By:

Liao, Mingxiang;
Zhu, Qing;
Zhu, Andy;
Gemski, Christopher;
Ma, Bingli;
Guan, Emily;
Li, Albert P.;
Xiao, Guangqing;
Xia, Cindy Q.

Publication type:

Article

Drug interactions between rifamycin antibiotics and hormonal contraception: a systematic review.

Published in:

2018

By:

Simmons, K. B.;
Haddad, L. B.;
Nanda, K.;
Curtis, K. M.

Publication type:

journal article

Controversy about the Role of Rifampin in Biofilm Infections: Is It Justified?

Published in:

Antibiotics (2079-6382), 2021, v. 10, n. 2, p. 165, doi. 10.3390/antibiotics10020165

By:

Renz, Nora;
Trampuz, Andrej;
Zimmerli, Werner;
Eick, Sigrun

Publication type:

Article

Evaluation of drug–drug interaction potential for pemigatinib using physiologically based pharmacokinetic modeling.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 7, p. 894, doi. 10.1002/psp4.12805

By:

Ji, Tao;
Chen, Xuejun;
Yeleswaram, Swamy

Publication type:

Article

Rifampin Regulation of Drug Transporters Gene Expression and the Association of MicroRNAs in Human Hepatocytes.

Published in:

Frontiers in Pharmacology, 2016, p. 1, doi. 10.3389/fphar.2016.00111

By:

Benson, Eric A.;
Eadon, Michael T.;
Desta, Zeruesenay;
Yunlong Liu;
Hai Lin;
Burgess, Kimberly S.;
Segar, Matthew W.;
Gaedigk, Andrea;
Skaar, Todd C.;
Honkakoski, Paavo

Publication type:

Article

A major compound isolated from Undaria Pinnatifida downregulates CYP3A4 and MDR1 expression by antagonizes pregnane X receptor activation.

Published in:

FASEB Journal, 2013, v. 27, p. 1180.9, doi. 10.1096/fasebj.27.1_supplement.1180.9

By:

Lim, Yun Ping;
Liu, Cheng Ling;
Hu, Miao Lin

Publication type:

Article

Rifampin–sirolimus–voriconazole interaction in a hematopoietic cell transplant recipient.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 1, p. 75, doi. 10.1177/1078155215624263

By:

Wasko, Justin A.;
Westholder, James S.;
Jacobson, Pamala A.

Publication type:

Article

Pharmacokinetics of haloperidol: an update.

Published in:

1999

By:

Kudo, S;
Ishizaki, T

Publication type:

journal article

Pharmacokinetics of Haloperidol.

Published in:

Clinical Pharmacokinetics, 1999, v. 37, n. 6, p. 435, doi. 10.2165/00003088-199937060-00001

By:

Kudo, Shoji;
Ishizaki, Takashi

Publication type:

Article

Decreased Serum Linezolid Levels in a Critically Ill Patient Receiving Concomitant Linezolid and Rifampin.

Published in:

Pharmacotherapy, 2007, v. 27, n. 3, p. 476, doi. 10.1592/phco.27.3.476

By:

Gebhart, Benjamin C.;
Barker, Brian C.;
Markewitz, Boaz A.

Publication type:

Article

Computational pharmacology of rifampin in mice: an application to dose optimization with conflicting objectives in tuberculosis treatment.

Published in:

Journal of Pharmacokinetics & Pharmacodynamics, 2014, v. 41, n. 6, p. 613, doi. 10.1007/s10928-014-9380-2

By:

Lyons, Michael

Publication type:

Article

Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor: Results of Drug‐Drug Interaction Studies in Patients With Advanced Solid Tumors or Lymphoma and a Physiologically Based Pharmacokinetic Analysis

Published in:

Journal of Clinical Pharmacology, 2018, v. 58, n. 2, p. 180, doi. 10.1002/jcph.988

By:

Gupta, Neeraj;
Hanley, Michael J.;
Venkatakrishnan, Karthik;
Bessudo, Alberto;
Rasco, Drew W.;
Sharma, Sunil;
O'Neil, Bert H.;
Wang, Bingxia;
Liu, Guohui;
Ke, Alice;
Patel, Chirag;
Rowland Yeo, Karen;
Xia, Cindy;
Zhang, Xiaoquan;
Esseltine, Dixie‐Lee;
Nemunaitis, John

Publication type:

Article

Possible Clinically Significant Interaction of Itraconazole Plus Rifampin.

Published in:

AIDS Patient Care & STDs, 2001, v. 15, n. 10, p. 505, doi. 10.1089/108729101753205667

By:

Todd, John R.;
Arigala, Mythili R.;
Penn, Robert L.;
King, John W.

Publication type:

Article

Effect of rifampin on the pharmacokinetics of bosutinib, a dual Src/Abl tyrosine kinase inhibitor, when administered concomitantly to healthy subjects.

Published in:

Drug Metabolism & Personalized Therapy, 2015, v. 30, n. 1, p. 57, doi. 10.1515/dmdi-2014-0026

By:

Abbas, Richat;
Boni, Joseph;
Sonnichsen, Daryl

Publication type:

Article

Clinically significant interactions with drugs used in the treatment of tuberculosis.

Published in:

2002

By:

Yew, W.;
Yew, W W

Publication type:

journal article

Risk-Benefit Assessment of Therapies for Mycobacterium avium Complex Infections.

Published in:

Drug Safety, 1999, v. 21, n. 2, p. 137, doi. 10.2165/00002018-199921020-00006

By:

Griffith, D.E.

Publication type:

Article

Tuberculosis in Solid-Organ Transplant Recipients: Consensus Statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology.

Published in:

Clinical Infectious Diseases, 2009, v. 48, n. 9, p. 1276, doi. 10.1086/597590

By:

Aguado, José María;
Torre-Cisneros, Julián;
Fortún, Jesús;
Benito, Natividad;
Meije, Yolanda;
Doblas, Antonio;
Muñoz, Patricia

Publication type:

Article

Tuberculosis and Illicit Drug Use: Review and Update.

Published in:

Clinical Infectious Diseases, 2009, v. 48, n. 1, p. 72, doi. 10.1086/594126

By:

Deiss, Robert G.;
Rodwell, Timothy C.;
Garfein, Richard S.

Publication type:

Article

Rifapentine for the Treatment of Pulmonary Tuberculosis.

Published in:

Clinical Infectious Diseases, 2006, v. 43, n. 11, p. 1468, doi. 10.1086/508278

By:

Munsiff, Sonal S.;
Kambili, Chrispin;
Ahuja, Shama Desai

Publication type:

Article

Effects of Single Dose Rifampin on the Pharmacokinetics of Fluvastatin in Healthy Volunteers.

Published in:

Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 2, p. 480, doi. 10.1002/cpt.2268

By:

Xiang, Yue;
Okochi, Hideaki;
Kozachenko, Ivan;
Sodhi, Jasleen K.;
Frassetto, Lynda A.;
Benet, Leslie Z.

Publication type:

Article

Predicting Drug-Drug Interactions Involving Multiple Mechanisms Using Physiologically Based Pharmacokinetic Modeling: A Case Study With Ruxolitinib.

Published in:

Clinical Pharmacology & Therapeutics, 2015, v. 97, n. 2, p. 177, doi. 10.1002/cpt.30

By:

Shi, JG;
Fraczkiewicz, G;
Williams, WV;
Yeleswaram, S

Publication type:

Article

Prediction of Rivaroxaban-Rifampin Interaction After Major Orthopedic Surgery: Physiologically Based Pharmacokinetic Modeling and Simulation.

Published in:

Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.706781

By:

Xu, Rui-juan;
Ling, Tao;
Tang, Hong;
Ge, Wei-hong;
Jiang, Qing

Publication type:

Article

Bernard–Soulier Syndrome (BSS) & tuberculosis: A case report.

Published in:

International Journal of Mycobacteriology, 2014, v. 3, n. 4, p. 283, doi. 10.1016/j.ijmyco.2014.10.006

By:

Hasanzad, Maryam

Publication type:

Article

Crizotinib for the treatment of non-small-cell lung cancer.

Published in:

American Journal of Health-System Pharmacy, 2013, v. 70, n. 11, p. 943, doi. 10.2146/ajhp120261

By:

TIMM, ANDREW;
KOLESAR, JILL M.

Publication type:

Article

Effects of rifampin coadministration on the pharmacokinetics of digoxin: a real-world data approach.

Published in:

Translational & Clinical Pharmacology, 2023, v. 31, n. 3, p. 148, doi. 10.12793/tcp.2023.31.e13

By:

JungJin Oh;
Byungwook Kim;
SeungHwan Lee

Publication type:

Article